Publications by authors named "Masato Okamoto"

Claim this Profile
L
Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.
Shuichi Hanada, Tomoko Tsuruta, Kouichi Haraguchi, Masato Okamoto, Haruo Sugiyama

Hum Vaccin Immunother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer.
Sayumi Yoshida, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Masato Okamoto

Cancer Invest· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1.
Zensho Ito, Shin Kan, Tsuuse Bito, Sankichi Horiuchi, Takafumi Akasu, Masato Okamoto

Oncology· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.
Tomoya Kanai, Zensho Ito, Yusuke Oji, Machi Suka, Sumiyuki Nishida, Masato Okamoto

Oncol Lett· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.
Tatsuo Matsuda, Hiroya Takeuchi, Toshiharu Sakurai, Shuhei Mayanagi, Eisuke Booka, Masato Okamoto

Oncol Lett· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.
Ryu Yanagisawa, Tomonobu Koizumi, Terutsugu Koya, Kenji Sano, Shigeo Koido, Masato Okamoto

Anticancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.
Koichi Hirabayashi, Ryu Yanagisawa, Shoji Saito, Yumiko Higuchi, Terutsugu Koya, Masato Okamoto

Anticancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of preoperative serum interleukin-6 levels in patients with early-stage oral squamous cell carcinoma, defined by sentinel node biopsy.
Hiroyuki Goda, Masato Okamoto, Koh-Ichi Nakashiro, Satoshi Hino, Ryuichi Murase

Oncol Lett· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.
Keitaro Fukuda, Takeru Funakoshi, Toshiharu Sakurai, Yoshio Nakamura, Mariko Mori, Masato Okamoto

Melanoma Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Wilms' tumor 1 antigen as a cancer vaccine for pancreatic cancer.
Shigeo Koido, Masato Okamoto, Masanori Kobayashi, Shigetaka Shimodaira, Haruo Sugiyama

Discov Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour site.
Kazuki Takakura, Zensho Ito, Machi Suka, Tomoya Kanai, Yoshihiro Matsumoto, Masato Okamoto

Scand J Gastroenterol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.
Shigeo Koido, Masato Okamoto, Shigetaka Shimodaira, Haruo Sugiyama

Immunotherapy· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis.
Hidenori Takahashi, Shigetaka Shimodaira, Masahiro Ogasawara, Shuichi Ota, Masanori Kobayashi, Masato Okamoto

Cancer Immunol Immunother· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-based cancer immunotherapy for colorectal cancer.
Mikio Kajihara, Kazuki Takakura, Tomoya Kanai, Zensho Ito, Keisuke Saito, Masato Okamoto

World J Gastroenterol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.
Mikio Kajihara, Kazuki Takakura, Tomoya Kanai, Zensho Ito, Yoshihiro Matsumoto, Masato Okamoto

World J Gastroenterol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-based vaccine for pancreatic cancer in Japan.
Masato Okamoto, Masanori Kobayashi, Yoshikazu Yonemitsu, Shigeo Koido, Sadamu Homma

World J Gastrointest Pharmacol Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
Keiichi Sakai, Shigetaka Shimodaira, Shinya Maejima, Nobuyuki Udagawa, Kenji Sano, Masato Okamoto

J Neurosurg· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells.
Shin Kan, Shigeo Koido, Masato Okamoto, Kazumi Hayashi, Masaki Ito

BMC Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy.
Shintaro Tsukinaga, Mikio Kajihara, Kazuki Takakura, Zensho Ito, Tomoya Kanai, Masato Okamoto

World J Gastroenterol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Large Number of Circulating Tumor Cells(CTCs)Can Be Isolated from Samples Obtained by Using Leukapheresis Procedures].
Ryoko Soya, Jyunichi Taguchi, Yuichi Nagakawa, Osamu Takahashi, Norimasa Sandoh, Masato Okamoto

Gan To Kagaku Ryoho· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.
Shin Kan, Shigeo Koido, Masato Okamoto, Kazumi Hayashi, Masaki Ito

Oncol Rep· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Corrigendum] Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells.
Shigeo Koido, Sadamu Homma, Shin Kan, Kazuki Takakura, Yoshihisa Namiki, Masato Okamoto

Int J Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.
Shuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, Tatsuo Matsuda, Tomonobu Fujita, Masato Okamoto

Cancer Sci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer.
Kazuki Takakura, Shigeo Koido, Shin Kan, Kosaku Yoshida, Masako Mori, Masato Okamoto

Anticancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer.
Shigeo Koido, Sadamu Homma, Masato Okamoto, Kazuki Takakura, Jianlin Gong

Oncoimmunology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis